NCT06866691View on ClinicalTrials.gov

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

PHASE4RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 18, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Traumatic Brain Injury
Interventions
DRUG

levetiracetam

levetiracetam 1000 mg intravenously or by mouth twice daily for a total of 7 days

DRUG

lacosamide

lacosamide 200 mg intravenously or by mouth twice daily for a total of 7 days

Trial Locations (1)

27157

RECRUITING

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT06866691 - Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide | Biotech Hunter | Biotech Hunter